Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2019-03-20 Report Publication Anno…
Country KR South Korea
Listing KO 303360

About PROTIA INC.

https://www.protia.co.kr/en/main

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최결과
Report Publication Announcement Classification · 1% confidence The document is a short, structured announcement (under 800 characters) reporting the results of an Investor Relations (IR) event held by ProteomeTech. It provides details such as the date, location, attendees, and a link to where the IR materials are posted. According to the 'Menu vs Meal' rule, since this is an announcement of an event and refers to the availability of materials rather than being the presentation itself, it is classified as a Report Publication Announcement (RPA).
2019-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a short announcement titled '감사보고서 제출' (Submission of Audit Report) dated 2019.03.14. It provides a summary table of audit opinions and key financial figures (assets, liabilities, revenue, etc.) rather than the full audit report itself. According to the 'Menu vs Meal' rule, since this is a brief announcement of the submission of the audit report, it is classified as a Report Publication Announcement (RPA). FY 2018
2019-03-14 Korean
기업설명회(IR)개최
Investor Presentation Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting, and explicitly states that materials will be distributed at the event and results will be disclosed later. Since it is an announcement of an event rather than the presentation slides themselves, and it is under 5,000 characters, it falls under the category of a Report Publication Announcement or general regulatory filing regarding corporate events.
2019-03-13 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for ProteomeTech. It includes the meeting agenda, details on management, board activities, and business outlook (management discussion). This type of document is standard for providing shareholders with the necessary information to vote on resolutions at an upcoming Annual General Meeting. In the context of financial filings, such documents are classified as Proxy Solicitation & Information Statements.
2019-03-08 Korean
기타주요경영사항(자율공시)(트리첵, 트리첵-C, 독일(EU) 등록 완료)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) from ProteomeTech regarding the regulatory approval of their products (TriCheck and TriCheck-C) in Germany/EU. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple announcement of a report publication. As it is a regulatory announcement of a material business event (product registration), it falls under the general regulatory filing category.
2019-02-26 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the regulatory approval of a medical device (Q-Processor) by the Korea Medical Device Safety Information Institute. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement. As it is a general regulatory announcement regarding company operations and product certification, it falls under the fallback category for regulatory filings.
2019-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.